Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOSERELIN for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 136 adverse event reports in the FDA FAERS database where GOSERELIN was used for Neoplasm malignant.

Most Reported Side Effects for GOSERELIN

Side Effect Reports % Deaths Hosp.
Death 1,293 20.3% 1,293 99
Malignant neoplasm progression 935 14.7% 85 114
Metastases to bone 397 6.2% 34 69
Neutropenia 339 5.3% 16 45
Fatigue 309 4.9% 27 76
Off label use 272 4.3% 22 68
Metastases to liver 264 4.1% 15 26
Hot flush 263 4.1% 23 47
Asthenia 213 3.3% 34 64
Arthralgia 190 3.0% 9 57
Drug ineffective 189 3.0% 21 55
Disease progression 181 2.8% 24 14
Nausea 177 2.8% 7 43
Pain 167 2.6% 16 50
Breast cancer 151 2.4% 10 10

Other Indications for GOSERELIN

Prostate cancer (2,080) Product used for unknown indication (1,345) Breast cancer (707) Breast cancer metastatic (396) Breast cancer female (190) Prostate cancer metastatic (136) Her2 positive breast cancer (99) Invasive ductal breast carcinoma (78) Endometriosis (76) Her2 negative breast cancer (67)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

GOSERELIN Full Profile All Neoplasm malignant Drugs GOSERELIN Demographics GOSERELIN Timeline